XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at Dec. 31, 2019 $ 27,779,543 $ 3,908 $ 314,511,853 $ (286,736,218)
Balance (in shares) at Dec. 31, 2019   39,084,121    
Exercise of stock options 797,629 $ 14 797,615  
Exercise of stock options (in shares)   135,013    
Stock-based compensation 2,198,187   2,198,187  
Net income (loss) (12,151,165)     (12,151,165)
Balance at Mar. 31, 2020 18,624,194 $ 3,922 317,507,655 (298,887,383)
Balance (in shares) at Mar. 31, 2020   39,219,134    
Balance at Dec. 31, 2019 27,779,543 $ 3,908 314,511,853 (286,736,218)
Balance (in shares) at Dec. 31, 2019   39,084,121    
Net income (loss) 9,265,598      
Balance at Sep. 30, 2020 58,022,903 $ 4,267 335,489,256 (277,470,620)
Balance (in shares) at Sep. 30, 2020   42,674,491    
Balance at Dec. 31, 2019 27,779,543 $ 3,908 314,511,853 (286,736,218)
Balance (in shares) at Dec. 31, 2019   39,084,121    
Balance at Dec. 31, 2020 $ 52,662,601 $ 4,272 337,453,776 (284,795,447)
Balance (in shares) at Dec. 31, 2020 42,721,566 42,721,566    
Balance at Mar. 31, 2020 $ 18,624,194 $ 3,922 317,507,655 (298,887,383)
Balance (in shares) at Mar. 31, 2020   39,219,134    
Issuance of common stock in public offering 5,178,460 $ 136 5,178,324  
Issuance of common stock in public offering (in shares)   1,361,956    
Costs related to issuance of common stock (219,517)   (219,517)  
Exercise of stock options 346,026 $ 7 346,019  
Exercise of stock options (in shares)   63,749    
Stock-based compensation 3,485,482   3,485,482  
Net income (loss) 29,529,376     29,529,376
Balance at Jun. 30, 2020 56,944,021 $ 4,065 326,297,963 (269,358,007)
Balance (in shares) at Jun. 30, 2020   40,644,839    
Issuance of common stock in public offering 7,371,609 $ 201 7,371,408  
Issuance of common stock in public offering (in shares)   2,019,652    
Costs related to issuance of common stock (236,149)   (236,149)  
Vesting of restricted stock units   $ 1 (1)  
Vesting of restricted stock units (in shares)   10,000    
Stock-based compensation 2,056,035   2,056,035  
Net income (loss) (8,112,613)     (8,112,613)
Balance at Sep. 30, 2020 58,022,903 $ 4,267 335,489,256 (277,470,620)
Balance (in shares) at Sep. 30, 2020   42,674,491    
Balance at Dec. 31, 2020 $ 52,662,601 $ 4,272 337,453,776 (284,795,447)
Balance (in shares) at Dec. 31, 2020 42,721,566 42,721,566    
Stock-based compensation $ 1,516,064   1,516,064  
Net income (loss) (8,804,733)     (8,804,733)
Balance at Mar. 31, 2021 45,373,932 $ 4,272 338,969,840 (293,600,180)
Balance (in shares) at Mar. 31, 2021   42,721,566    
Balance at Dec. 31, 2020 $ 52,662,601 $ 4,272 337,453,776 (284,795,447)
Balance (in shares) at Dec. 31, 2020 42,721,566 42,721,566    
Net income (loss) $ (28,599,303)      
Balance at Sep. 30, 2021 $ 28,077,948 $ 4,272 341,468,426 (313,394,750)
Balance (in shares) at Sep. 30, 2021 42,721,566 42,721,566    
Balance at Mar. 31, 2021 $ 45,373,932 $ 4,272 338,969,840 (293,600,180)
Balance (in shares) at Mar. 31, 2021   42,721,566    
Stock-based compensation 1,384,060   1,384,060  
Net income (loss) (10,589,163)     (10,589,163)
Balance at Jun. 30, 2021 36,168,829 $ 4,272 340,353,900 (304,189,343)
Balance (in shares) at Jun. 30, 2021   42,721,566    
Stock-based compensation 1,114,526   1,114,526  
Net income (loss) (9,205,407)     (9,205,407)
Balance at Sep. 30, 2021 $ 28,077,948 $ 4,272 $ 341,468,426 $ (313,394,750)
Balance (in shares) at Sep. 30, 2021 42,721,566 42,721,566